Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Markets Investing.com By Investing.com 17 Jun 2026 15:06 1 min read

Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.